Miranda Versloot

851 total citations
19 papers, 459 citations indexed

About

Miranda Versloot is a scholar working on Immunology, Surgery and Oncology. According to data from OpenAlex, Miranda Versloot has authored 19 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 6 papers in Surgery and 6 papers in Oncology. Recurrent topics in Miranda Versloot's work include Atherosclerosis and Cardiovascular Diseases (10 papers), Lipoproteins and Cardiovascular Health (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Miranda Versloot is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (10 papers), Lipoproteins and Cardiovascular Health (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Miranda Versloot collaborates with scholars based in Netherlands, United States and Canada. Miranda Versloot's co-authors include Erik S.G. Stroes, Jeffrey Kroon, Sophie J. Bernelot Moens, Jan Paul Medema, Simone L. Verweij, Menno P.J. de Winther, Michel van Weeghel, Koen H.M. Prange, Dominique P.V. de Kleijn and Sotirios Tsimikas and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Circulation Research.

In The Last Decade

Miranda Versloot

19 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miranda Versloot Netherlands 10 163 142 113 97 77 19 459
Aiko Shimokado Japan 10 112 0.7× 210 1.5× 233 2.1× 51 0.5× 86 1.1× 18 607
José A. López United States 10 91 0.6× 161 1.1× 65 0.6× 63 0.6× 41 0.5× 19 500
Wenjiang Yan China 12 275 1.7× 209 1.5× 38 0.3× 186 1.9× 73 0.9× 18 595
Rui‐Yi Lu China 8 183 1.1× 202 1.4× 68 0.6× 43 0.4× 107 1.4× 13 477
S. Takahashi Japan 11 135 0.8× 164 1.2× 63 0.6× 48 0.5× 54 0.7× 33 455
Naohiro Ohashi Japan 7 116 0.7× 178 1.3× 77 0.7× 81 0.8× 48 0.6× 9 433
Tamara Djurić Serbia 13 98 0.6× 134 0.9× 36 0.3× 85 0.9× 122 1.6× 52 409
Xiaoxu Ge China 14 96 0.6× 355 2.5× 89 0.8× 135 1.4× 326 4.2× 40 644
T. I. Arefieva Russia 11 173 1.1× 106 0.7× 83 0.7× 68 0.7× 49 0.6× 47 395
Verónica M. Dardé Spain 15 101 0.6× 241 1.7× 81 0.7× 35 0.4× 124 1.6× 26 549

Countries citing papers authored by Miranda Versloot

Since Specialization
Citations

This map shows the geographic impact of Miranda Versloot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda Versloot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda Versloot more than expected).

Fields of papers citing papers by Miranda Versloot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miranda Versloot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda Versloot. The network helps show where Miranda Versloot may publish in the future.

Co-authorship network of co-authors of Miranda Versloot

This figure shows the co-authorship network connecting the top 25 collaborators of Miranda Versloot. A scholar is included among the top collaborators of Miranda Versloot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miranda Versloot. Miranda Versloot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hanford, K.J., Kim E. Dzobo, Miranda Versloot, Jorge Peter, & Jeffrey Kroon. (2025). Protocol to generate a 3D atherogenesis-on-chip model for studying endothelial-macrophage crosstalk in atherogenesis. STAR Protocols. 6(1). 103559–103559. 1 indexed citations
2.
Dzobo, Kim E., Arjen J. Cupido, Lotte C.A. Stiekema, et al.. (2024). Diacylglycerols and Lysophosphatidic Acid, Enriched on Lipoprotein(a), Contribute to Monocyte Inflammation. Arteriosclerosis Thrombosis and Vascular Biology. 44(3). 720–740. 28 indexed citations
3.
Vegting, Yosta, Aldo Jongejan, Miranda Versloot, et al.. (2024). Cardiovascular risk in ANCA-associated vasculitis: Monocyte phenotyping reveals distinctive signatures between serological subsets. Atherosclerosis. 397. 118559–118559. 3 indexed citations
4.
Wasiak, Sylwia, Kim E. Dzobo, Brooke D. Rakai, et al.. (2020). BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes. Clinical Epigenetics. 12(1). 166–166. 31 indexed citations
5.
Hoogeveen, Renate M., Koen H.M. Prange, Michel van Weeghel, et al.. (2020). Atherogenic lipoprotein(A) increases vascular glycolysis, thereby facilitating inflammation and leukocyte extravasation. Atherosclerosis. 315. e10–e11. 2 indexed citations
6.
Schnitzler, Johan G., Renate M. Hoogeveen, Lubna Ali, et al.. (2020). Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation. Circulation Research. 126(10). 1346–1359. 131 indexed citations
7.
Pavanello, Chiara, Kang H. Zheng, Jeffrey Kroon, et al.. (2019). Low Hdl-Cholesterol Levels Are Associated With A Decreased Monocyte Activity And Inflammation In Carriers Of Lcat Mutation. Atherosclerosis. 287. e23–e24. 2 indexed citations
8.
Verweij, Simone L., Lotte C.A. Stiekema, Ronak Delewi, et al.. (2018). Prolonged hematopoietic and myeloid cellular response in patients after an acute coronary syndrome measured with 18F-DPA-714 PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 45(11). 1956–1963. 9 indexed citations
9.
10.
Verweij, Simone L., Raphaël Duivenvoorden, Lotte C.A. Stiekema, et al.. (2017). CCR2 expression on circulating monocytes is associated with arterial wall inflammation assessed by 18F-FDG PET/CT in patients at risk for cardiovascular disease. Cardiovascular Research. 114(3). 468–475. 42 indexed citations
11.
Moens, Sophie J. Bernelot, Sander I. van Leuven, Kang H. Zheng, et al.. (2016). Impact of the B Cell Growth Factor APRIL on the Qualitative and Immunological Characteristics of Atherosclerotic Plaques. PLoS ONE. 11(11). e0164690–e0164690. 10 indexed citations
12.
Alaarg, Amr, Kang H. Zheng, Fleur M. van der Valk, et al.. (2016). Multiple pathway assessment to predict anti-atherogenic efficacy of drugs targeting macrophages in atherosclerotic plaques. Vascular Pharmacology. 82. 51–59. 9 indexed citations
13.
Moens, Sophie J. Bernelot, Simone L. Verweij, Fleur M. van der Valk, et al.. (2016). Arterial and Cellular Inflammation in Patients with CKD. Journal of the American Society of Nephrology. 28(4). 1278–1285. 49 indexed citations
14.
Alaarg, Amr, Anouk A.J. Hamers, Miranda Versloot, et al.. (2015). Targeted liposomal drug delivery to inhibit atherosclerotic plaque inflammation. Atherosclerosis. 241(1). e87–e87. 4 indexed citations
15.
Nicolaes, Gerry A. F., et al.. (2014). The structure function of the death domain of human IRAK-M. Cell Communication and Signaling. 12(1). 77–77. 28 indexed citations
16.
Du, Jiangfeng, et al.. (2014). The structure function of the death domain of human IRAK-M. Cell Communication and Signaling. 12(1). 77–77. 2 indexed citations
17.
Kemper, Kristel, Miranda Versloot, Katherine Cameron, et al.. (2012). Mutations in the Ras–Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer. Clinical Cancer Research. 18(11). 3132–3141. 76 indexed citations
18.
Kimberley, Fiona C., Almer M. van der Sloot, Marco Guadagnoli, et al.. (2012). The Design and Characterization of Receptor-selective APRIL Variants. Journal of Biological Chemistry. 287(44). 37434–37446. 7 indexed citations
19.
Cameron, Kate, Marco Guadagnoli, Miranda Versloot, et al.. (2012). The TNF family member APRIL promotes colorectal tumorigenesis. Cell Death and Differentiation. 19(11). 1826–1835. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aiko Shimokado Breakdown of academic impact, for papers by José A. López Breakdown of academic impact, for papers by Wenjiang Yan Breakdown of academic impact, for papers by Rui‐Yi Lu Breakdown of academic impact, for papers by S. Takahashi Breakdown of academic impact, for papers by Naohiro Ohashi Breakdown of academic impact, for papers by Tamara Djurić Breakdown of academic impact, for papers by Xiaoxu Ge Breakdown of academic impact, for papers by T. I. Arefieva Breakdown of academic impact, for papers by Verónica M. Dardé
Rankless by CCL
2026